GD2

GD2 is a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression
on normal tissues, principally to the cerebellum and peripheral nerves in humans. The relatively tumor specific expression of GD2 makes it a suitable target for immunotherapy with monoclonal antibodies or with artificial T cell receptors.

NodeWorks boosts web surfing!

Page Returned in 0.190 seconds - HTML Compressed 69.1%

This article is from Wikipedia. All text is available
under the terms of the GNU Free Documentation License.